The COVID-19 pandemic caused massive disruptions in global biomedical research. These disruptions were acutely felt in the conduct of clinical trials. The pandemic has forced the key players to find new ways to keep clinical trials on the track that are both effective and cost-efficient.
According to the US Department of Health and Human Services, clinical trials cost $ 4 - 20million. There are several reasons why clinical studies are so costly l, but the limitations of research methodology and poor recruitment make an especially significant contribution. Virtual trials have been put forward as a potential way to reduce costs and make it easier for patients to take part in studies. A virtual clinical trial is not conducted in an environment such as a clinic or a hospital but instead can be conducted through remote interaction (mobile phone, apps, etc.) between patients and investigators.
The first “virtual” drug study, where the participants were communicating with the organizers remotely, was conducted for the first time in 2011 in the USA by Pfizer Virtual trials allowing researchers to reach diverse populations and difficult-to-recruit candidates. Built on a foundation of global clinical operations capabilities, virtual trials solve some of the toughest study challenges through innovative research designs that can be customized for any trial type or indication. As a clinical trial supply and logistics provider focused on advancing drug development, COREX Logistics is committed to supporting research that will enable us to help patients live better lives sooner rather than later.
We're excited by all of the possibilities virtual clinical trials bring including:
At COREX Logistics we are keeping pace with these developments investing in new technologies to make the supply chain more transparent, transportation more efficient and most importantly getting vital medicines to patients safely and on time. We’re also investing in our people who will drive digital transformation.